| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |